Jared Wolff, Zach McLellan, Jack Allen, and Maha Elsayed discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.

This week we have a special guest joining us! Dan Chancellor is the Lead Analyst for Central Nervous System and Rare Diseases at Datamonitor Healthcare.

Topics covered in this episode include: - CAR-T Overview: Novartis’s accelerated approval for CTL-019 and Kite’s updated trial data for KTE-019 (0:43) - Approval of Tesaro's Zejula in both BRCA and non-BRCA mutated ovarian cancer patients (9:06) - Approval of Roche's Ocrevus relapsing in primary progressive forms of multiple sclerosis (17:50)

To learn more about Datamonitor Healthcare and our offerings, visit:

https://exit.sc/?url=https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fdatamonitor-healthcare